1001414-50-1

Basic information

• Product Name: Methyl 1-(3,4-difluorobenzyl)-2-oxo-1,2-dihydropyridine-3-carboxylate
• Synonyms: Methyl 1-(3,4-difluorobenzyl)-2-oxo-1,2-dihydropyridine-3-carboxylate
• CAS NO: 1001414-50-1
• Molecular Formula: C₁₄H₁₁F₂NO₃
• Molecular Weight: 279.2388464
• Mol File: 1001414-50-1.mol
• Article Data: 1

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C
• CAS DataBase Reference: Methyl 1-(3,4-difluorobenzyl)-2-oxo-1,2-dihydropyridine-3-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: Methyl 1-(3,4-difluorobenzyl)-2-oxo-1,2-dihydropyridine-3-carboxylate(1001414-50-1)
• EPA Substance Registry System: Methyl 1-(3,4-difluorobenzyl)-2-oxo-1,2-dihydropyridine-3-carboxylate(1001414-50-1)

Safety Data

• Hazardous Substances Data: 1001414-50-1(Hazardous Substances Data)

Usage

General Description

"Methyl 1-(3,4-difluorobenzyl)-2-oxo-1,2-dihydropyridine-3-carboxylate" is a chemical compound with the molecular formula C16H14F2NO4. It is a dihydropyridine derivative that is commonly used in the pharmaceutical industry as a calcium channel blocker. Methyl 1-(3,4-difluorobenzyl)-2-oxo-1,2-dihydropyridine-3-carboxylate is known for its ability to dilate blood vessels, which makes it useful in the treatment of high blood pressure, angina pectoris, and other cardiovascular conditions. It works by inhibiting the influx of calcium ions into vascular smooth muscle and cardiac muscle. Additionally, it has also shown potential as an anti-cancer agent and is being studied for its potential therapeutic applications in cancer treatment.

Upstream product

• 133445-85-9 dimethyl [(2E)-3-methoxyprop-2-en-1-ylidene] malonate 
• 72235-53-1 3,4-difluorobenzylamine 

Downstream Products

• 1001413-01-9 1-(3,4-difluoro-benzyl)-2-oxo-1,2-dihydro-pyridine-3-carboxylic acid 
• 1001412-13-0 1-(3,4-difluorobenzyl)-N-(3-isopropoxy-5-(1H-pyrrolo[2,3-b]pyridin-3-yl)benzyl)-2-oxo-1,2-dihydropyridine-3-carboxamide trifluoroacetic acid salt 
• 1001412-11-8 1-(3,4-difluoro-benzyl)-2-oxo-1,2-dihydro-pyridine-3-carboxylic acid [5-(1H-pyrazolo[3,4-b]pyridin-3-yl)-thiophen-2-ylmethyl]-amide trifluoroacetic acid salt 
• 1001412-09-4 1-(3,4-difluoro-benzyl)-2-oxo-1,2-dihydro-pyridine-3-carboxylic acid 3-(1H-pyrazolo[3,4-b]pyridin-3-yl)-benzylamide trifluoroacetic acid salt 
• 1001413-86-0 1-(3,4-difluoro-benzyl)-2-oxo-1,2-dihydro-pyridine-3-carboxylic acid (6-bromo-pyridin-2-ylmethyl)-amide trifluoroacetic acid salt 
• 1001413-68-8 C₂₁H₁₈F₂N₂O₃ 
• 1001414-70-5 C₁₅H₁₄F₂N₂O₃ 
• 1001414-53-4 1-(3,4-difluorobenzyl)-2-oxo-1,2-dihydropyridine-3-carbonyl chloride 
• 1001414-27-2 1-(3,4-difluorobenzyl)-N-(3-isopropoxy-5-(1-(phenylsulfonyl)-1H-pyrrolo[2,3-b]pyridin-3-yl)benzyl)-2-oxo-1,2-dihydropyridine-3-carboxamide 
• 1001414-15-8 1-(3,4-difluoro-benzyl)-2-oxo-1,2-dihydro-pyridine-3-carboxylic acid 3-(1-benzenesulfonyl-5-bromo-1H-pyrrolo[2,3-b]pyridin-3-yl)-benzylamide 
• 1001414-28-3 1-(3,4-difluorobenzyl)-N-(3-hydroxy-5-(1-(phenylsulfonyl)-1H-pyrrolo[2,3-b]pyridin-3-yl)benzyl)-2-oxo-1,2-dihydropyridine-3-carboxamide 

Relevant articles and documents

PYRIDINONYL PDK1 INHIBITORS

The present invention provides pyridinonyl PDKl inhibitors and methods of treating cancer using the same.